source
- Biogen CEO says early-stage R&D now a priority after record five INDs this yearBiogen's chief executive Chris Viehbacher told analysts that the company has shifted its strategy toward early-stage research and development. He highlighted that Biogen has filed five investigati…
- Flagship launches Etcelera, an AI-driven biotech combining three platforms to predict drug effectsFlagship Pioneering announced the formation of Etcelera, a new biotech emerging from stealth that will focus on AI-powered drug discovery. The company brings together the technologies of Cellarity…